Table 3.
S-IgG at T2 (U/mL) | <0.8 | ≥0.8 | <200 | ≥200 | |
---|---|---|---|---|---|
n | 1 | 29 | 21 | 9 | |
Median, /μL (IQR) | p value | ||||
Total lymphocytes | 1343 | 1227 (1020–1904) | 1227 (1000–1809) | 1275 (1144–1924) | 0.46 |
CD3+ | 926 | 892 (649–1144) | 943 (727–1144) | 728 (649–910) | 0.38 |
CD4+ | 147 | 351 (263–516) | 333 (242–516) | 351 (270–513) | 0.95 |
CD8+ | 711 | 369 (219–692) | 421 (263–695) | 286 (219–556) | 0.5 |
CD3 + HLA-DR + | 805 | 398 (277–799) | 398 (338–805) | 451 (191–775) | 0.97 |
CD19+ | 0 | 46 (22–169) | 35 (19–74) | 114 (61–248) | 0.016 |
CD56+ | 376 | 167 (45–303) | 85 (23–290) | 231 (131–285) | 0.22 |